Why Biomarker Testing Matters in AML

добавлена новая статья Health

2026-09-30 09:56:27 - Перевод -

Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow that requires prompt diagnosis and treatment. In recent years, biomarker testing has become essential to AML care, providing information about the genetic and molecular characteristics of the disease. This information helps clinicians classify AML, determine prognosis, and select the most appropriate therapies. Without...

0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр